Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Harvard Business School
Daiichi Sankyo
Deloitte
Healthtrust
Cerilliant
Baxter
Covington

Generated: April 25, 2018

DrugPatentWatch Database Preview

THIOSULFIL Drug Profile

« Back to Dashboard

Which patents cover Thiosulfil, and when can generic versions of Thiosulfil launch?

Thiosulfil is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in THIOSULFIL is sulfamethizole. There are four drug master file entries for this compound. Additional details are available on the sulfamethizole profile page.
Drug patent expirations by year for THIOSULFIL
Medical Subject Heading (MeSH) Categories for THIOSULFIL
Synonyms for THIOSULFIL
[(4-aminophenyl)sulfonyl](5-methyl(1,3,4-thiadiazol-2-yl))amine
144-82-1
2-(p-Aminobenzenesulfonamido)-5-methylthiadiazole
2-Methyl-5-sulfanilamido-1,3,4-thiadiazole
2-Sulfanilamido-5-methyl-1,3,4-thiadiazole
25W8454H16
2735AH
4-Amino-N-(5-Methyl-1,3,4-Thiadiazol-2-Yl)Benzene-1-Sulfonamide
4-Amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide
4-amino-N-(5-methyl[1,3,4]thiadiazol-2-yl)-benzenesulfonamide
4-amino-n-[5-methyl-1,3,4-thiadiazol-2-yl]-benzenesulfonamide
4-Amino-N-[5-methyl-1,3,4-thiadiazol-2-yl]benzenesulfonamide
4-oxo-3-phenyl-10-oxa-3-aza-tricyclo[5.2.1.0*1,5*] dec-8-ene-6-carboxylic acid
5-Methyl-2-sulfanilamido-1,3,4-thiadiazole
AB00052098
AB00052098_15
AB00052098_16
AB2000390
ABA-10163325
AC1L1K3Z
AC1Q2PXR
AI3-50149
AKOS002666345
AN-43960
ANW-43072
API0004271
AS-10177
Ayerlucil
B2039
BDBM50295558
Benzenesulfonamide, 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)-
benzenesulfonamide,4-amino-n-(5-methyl-1,3,4-thiadiazol-2-yl)-
BPBio1_000798
BRD-K31682896-001-05-9
BSPBio_000724
BSPBio_001960
C08050
C9H10N4O2S2
CAS-144-82-1
CCG-39260
CCRIS 756
CHEBI:9331
CHEMBL1191
CS-2375
CTK8B3741
D00870
D07JJS
DB00576
DivK1c_000141
DSSTox_CID_3615
DSSTox_GSID_23615
DSSTox_RID_77111
DTXSID5023615
EINECS 205-641-1
Epitope ID:122233
Famet
HE056207
HE311826
HMS1570E06
HMS1921A19
HMS2092I21
HMS2097E06
HMS2233L09
HMS3371A13
HMS3655F05
HMS500H03
HSDB 4379
HY-B0333
IDI1_000141
J-008011
KB-271162
KBio1_000141
KBio2_001472
KBio2_004040
KBio2_006608
KBio3_001460
KBioGR_001260
KBioSS_001472
KS-000014AV
LS-853
Lucosil
MCULE-8287230974
Methazol
MFCD00053363
Microsul
MLS000028603
MLS002303066
MolPort-000-876-475
N(1)-(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanilamide
N(sup 1)-(5-Methyl-1,3,4-thiadiazol-2-yl)-sulfanilamide
N(sup 1)-(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanilamide
N1-(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanilamide
NCGC00016407-01
NCGC00016407-02
NCGC00016407-03
NCGC00016407-04
NCGC00016407-05
NCGC00016407-06
NCGC00016407-07
NCGC00016407-08
NCGC00016407-09
NCGC00016407-11
NCGC00024107-03
NCGC00024107-04
NCGC00024107-05
NCGC00258588-01
NINDS_000141
NSC-757327
NSC757327
Opera_ID_1595
Pharmakon1600-01500549
Prestwick_114
Prestwick0_000742
Prestwick1_000742
Prestwick2_000742
Prestwick3_000742
Proklar
Renasul
RP 2145
Rufol
S0360
s1957
Salimol
SBB058179
SBI-0051523.P003
SC-62410
SCHEMBL26453
SMP1_000284
SMR000058666
Solfametizolo
Solfametizolo [DCIT]
SPBio_001443
SPBio_002663
Spectrum_000992
SPECTRUM1500549
Spectrum2_001322
Spectrum3_000570
Spectrum4_000640
Spectrum5_001078
SR-01000003158
SR-01000003158-2
ST51015120
Sulamethizole
Sulfa gram
Sulfamethazole
SULFAMETHIAZOLE
Sulfamethizol
sulfamethizole
Sulfamethizole (JP15/USP/INN)
Sulfamethizole (JP17/USP/INN)
Sulfamethizole (Proklar)
Sulfamethizole [USAN:INN:JAN]
Sulfamethizole [USP:INN:BAN:JAN]
Sulfamethizole, analytical standard, >=99% (HPLC)
Sulfamethizole, European Pharmacopoeia (EP) Reference Standard
Sulfamethizole, United States Pharmacopeia (USP) Reference Standard
Sulfamethizole, VETRANAL(TM), analytical standard
Sulfamethizolum
Sulfamethizolum [INN-Latin]
Sulfamethylthiadiazole
Sulfametizol
Sulfametizol [INN-Spanish]
Sulfanilamide, N(sup 1)-(5-methyl-1,3,4-thiadiazol-2-yl)-
Sulfapyelon
Sulfstat
Sulfurine
sulphamethazole
sulphamethiozole
Sulphamethizole
Sulphamethyltiadiazole
Tetracid
Thidicur
Thiosulfil (TN)
Thiosulfil Forte
Thiosulfil-A-Forte
Tox21_110425
Tox21_110425_1
Tox21_201035
TR-043817
Ultrasul
UNII-25W8454H16
Urocydal
Urodiaton
Urolucosil
Urosulfin
Uroz
VACCAVUAMIDAGB-UHFFFAOYSA-N
VK 53
ZINC57493

US Patents and Regulatory Information for THIOSULFIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst THIOSULFIL sulfamethizole TABLET;ORAL 008565-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst THIOSULFIL sulfamethizole TABLET;ORAL 008565-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Argus Health
Mallinckrodt
Chubb
Federal Trade Commission
Deloitte
Merck
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.